- ►ahajournals.org J Su, PA Lucchesi, RA Gonzalez-Villalobos, … - … , and vascular biology, 2008 - Am Heart Assoc Methods and Results— Type 2 diabetic db – /db – (diabetic) and nondiabetic db – /db +
(control) mice were treated with the AGE inhibitor (aminoguanidine: 50 mg/Kg/d) for 3
months. Isolated mesenteric resistance arteries (MRAs) were mounted in an arteriograph. ... Cited by 12 - Related articles - All 10 versions
D Senador, K Kanakamedala, MC Irigoyen, M … - Experimental …, 2009 - Physiological Soc The db/db mice serve as a good model for type 2 diabetes characterized by hyperinsulinaemia
and progressive hyperglycaemia. There are limited and conflicting data on the cardiovascular
changes in this model. The aim of the present study was to characterize the ... Cited by 1 - Related articles - All 8 versions
DI Palen, K Matrougui - Diabetes/metabolism research and …, 2008 - pubmedcentral.nih.gov Type 2 diabetes is associated with microvascular complications. We hypothesized that the sustained
elevated EGFR phosphorylation produces structural wall remodeling and altered mechanical
properties of mesenteric resistance artery (MRA) in type 2 diabetes. Related articles - All 3 versions
SHI Yi, PM VANHOUTTE, PM Vanhoutte - interscience.wiley.com Vascular complications are an important pathological issue in diabetes, which lead to further
functional deterioration of several organs. The balance between endothelium-dependent relaxing
(EDRF) and endothelium-dependent contracting (EDCF) factors is crucial in controlling ... Related articles
JB Su, R Hoüel, F Héloire, F Barbe, F Beverelli, L … - Circulation, 2005 - pt.wkhealth.com From the Experimental Nuclear Cardiology Laboratory, Division of Cardiovascular Medicine,
Department of Internal Medicine, and Department of Diagnostic Radiology, Yale University School
of Medicine, New Haven, Conn (HS, LWD, JS, JH, DPD, PC, CC, BNB, X.-YH, AJS); the ... Related articles - All 2 versions
HJ Tsai, SY Chou - Journal of Biomedical Science, 2009 - pubmedcentral.nih.gov Diabetes Mellitus is a chronic disease and many patients of which require frequent subcutaneous
insulin injection to maintain proper blood glucose levels. Due to the inconvenience of insulin
administration, an orally active insulin replacement has long been a prime target for many ... Related articles - All 4 versions